The effect of inducible nitric oxide synthase inhibitor on microvascular permeability after cerebral ischemia/reperfusion

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 27, Issue 10, 2005, Pages 701-704

  Yao, Yu ^a   Zhou, J Y ^b   Zhu, X J ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Aminguanidine (AG); Cerebral ischemia reperfusion; Microvascular permeability; Nitric oxide (NO)

Indexed keywords

AMINOGUANIDINE; FLUORESCEIN SODIUM; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE; MALE; MICROVASCULATURE; NONHUMAN; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

ANIMALS; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; ENZYME INHIBITORS; GUANIDINES; MALE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION;

EID: 33144480869     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2005.27.10.948913     Document Type: Article

References (29)

1. Cipolla, M.J., Crete, R., Vitullo, L. et al. Transcellular transport as a mechanism of blood-brain barrier disruption during stroke. Front Biosci 2004, 9: 777-85.
2. Krizanac-Bengez, L., Kapural, M., Parkinson, F. et al. Effects of transient loss of shear stress on blood-brain barrier endothelium: Role of nitric oxide and IL-6. Brain Res 2003, 977: 239-46.
3. del Zoppo, G.J., Hallenbeck, J.M. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 2000, 98: v73-v81.
4. Stanness K.A., Westrum, L.E., Mascagni, P. et al. Morphological and functional characterization of an in vitro blood-brain barrier model. Brain Res 1997, 771: 329-42.
5. Janigro, D., West, G.A., Nguyen, T.S. et al. Regulation of blood-brain barrier endothelial cells by nitric oxide. Circ Res 1994, 75: 528-38.
6. Utepbergenov, D.I., Mertsch, K., Sporbert, A. Nitric oxide protects blood-brain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS 1998, 424: 197-201.
7. Iadecola, C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997, 20: 132-9.
8. Oliver, J.A. Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 1992, 151: 506-11.
9. Gursoy, O.Y., Bolay, H., Saribas, O. Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 2000, 31: 1974-81.
10. Tilton, R.G., Chang, K.C., LeJeune, W.S. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. Invest Ophthalmol Visual Sci 1999, 40: 686-96.
11. Li, D.Z., Catherine, M.V., Nicole, C. L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice. Eur J Pharm 2002, 457: 137-46.
12. Mayhan, W.G. Role of nitric oxide in histamine induced increases in permeability of the blood-brain barrier. Brain Res 1996, 743: 70-6.
13. Kroll, R.A., Neuwett, E.A. Outwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means. Neurosurgery 1998, 42: 1083-100.
14. Lafuente, J.V., Pouschman, E., Cervos-Navarro, J. Dynamics of tracer distribution in radiation induced brain oedema in rats. Acta Neurochir 1990, 51(Suppl): 375-7.
15. Kozler, P., Pokorny, J. Altered blood-brain barrier permeability and its effect on the distribution of evans blue and sodium fluorescein in the rat brain applied by intracarotid injection. Physiol Res 2003, 52: 607-14.
16. Rapoport, S.I. Osmotic opening of the blood-brain barrier: Principles, mechanism, and therapeutic applications. Cell Mol Neurobiol 2000, 20: 217-30.
17. Thompson, S.E., Cavitt, J., Audus, K.L. Leucine enkephaline effects on paracellular and transcellular pathways across brain microvessel endothelial cell monolayers. J Cardiovasc Pharmacol 1994, 24: 818-25.
18. Zhang, J., Benveniste, H., Klitzman, B. et al. Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion. Stroke 1995, 26: 298-304.
19. Risau, W., Wolburg, H. Development of the blood-brain barrier. Trends Neurosci 1990, 13: 174-8.
20. Solenski, N.J., Kwan, A. Attenuation of free radical generation during reversible focal cerebral ischemia with the nitric oxide inhibiter, L-NAME (L-NCG)-nitro-L-arginine methyl ester). Brain Res 2000, 862: 262-5.
21. Shimada, Y., Yokoyama, K., Goto, H. Protective effect of keishi-bukuryo-gan and its constituent medicinal plants against nitric oxide donor-induced neuronal death in cultured cerebellar granule cells. Phytomedicine 2004, 11: 404-10.
22. Keynes, R.G., Garthwaite, J. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med 2004, 4: 179-91.
23. Corbett, J.A., McDaniel, M.L. Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Methods Enzymol 1996, 268: 398-408.
24. Cockroft, K.M., Meistrell, M., III, Zimmerman, G.A. Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 1996, 27: 1393-8.
25. Cash, D., Beech, J.S., Rayne, R.C. Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain. Brain Res 2001, 905: 91-103.
26. Tsuji, M., Higuchi, Y., Shiraishi, K. Protective effect of amino-guanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr Res 2000, 47: 79-83.
27. Takizawa, S., Hirabayashi, H., Fukuyama, N. et al. Peroxynitrite production in cerebral ischemia. Rinsho Shinkeigaku 1999, 39: 1295-7.
28. Takizawa, S., Hirabayashi, H., Fukuyama, N. et al. Dynamics of nitrotyrosine formation and decay in rat brain during focal ischemia- reperfusion. J Cereb Blood Flow Metab 1999, 19: 667-72.
29. Mollace, U., Nistico, G. Release of nitric oxide from astroglial cells: A key mechanism in neuroimmune disorders. Adv Neuroimmunol 1995, 5: 421-30.